首页> 外国专利> Preparation procedure of organic tin progressive light protective powder; use of organic tin progressive light protective powder, including composition, precursor and preparation procedure of such precursor

Preparation procedure of organic tin progressive light protective powder; use of organic tin progressive light protective powder, including composition, precursor and preparation procedure of such precursor

机译:有机锡渐进式光防护粉的制备工艺;有机锡渐进光保护粉的用途,包括组成,前体及其制备方法

摘要

This application relates to organosilicon Polymers containing Esters of benzoic acid in the form of particles, Process for their preparation, Dermatological or cosmetic composition which comprises, as well as its use to protect a Body of a human or animal Alive The UV Radiation.Claim 1: a procedure for the preparation of a Progressive organosilicon photoresist Polymer, characterized in that it comprises the reaction of monomers of formula (1): in which R is selected from the group consisting of compounds of the formula (2), (3) and (4), in which Ru00b9 Ru00b2 ru00b3:,,, and ru2074 ru2075 are selected independently from the group consisting of H,Cu2081u208bu2086 linear or branched alkyl, cycloalkyl cu2083u208bu2086, oru00b9u2070, nhu2082, nhru00b9u00b9, nru00b9u00b2ru00b9u00b3, COOH, cooru00b9u2074, conhu2082, conhru00b9u2075, conru00b9u2076ru00b9u2077, sou2082nhu2082, sou2082nhru00b9u2078 sou2082nru00b9u2079ru00b2u2070, and under the condition that at least one of ru00b9, Ru00b2, ru00b3, ru2074 and ru2075 is not always that the h Least one of ru00b9 and ru2075 h; ru2076, ru2077, ru2078 and ru2079 are selected irrespective of hydrogen cu2081u208bu2086 linear or branched alkyl, cycloalkyl, cu2083u208bu2086, oru00b9, nhu2082,Nhru00b2 and nru00b3ru2074; ru00b9u2070 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; ru00b9u00b9 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u00b2 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u00b3 is linear or branched alkyl cu2081u208bu2086 or cycle Rent cu2083u208bu2086; or ru00b9u00b2 and ru00b9u00b3 taken together with the nitrogen Atom to which they are United to form a Ring of pyrrolidineRu00b9u2074 alkyl morpholine or piperidine; cu2081u208bu2086 is linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u2075 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u2076 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u2077 is linear or ramificad cu2081u208bu2086 Cu2083u208bu2086 or cycloalkyl or ru00b9u2076 and ru00b9u2077; taken together with the nitrogen Atom to which they are United to form a Ring of pyrrolidinePiperidine and morpholine; ru00b9u2078 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; ru00b9u2079 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; ru00b2u2070 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; or ru00b9u2079 and ru00b2u2070 taken together with the NITROGEN Atom that are United to form a Ring of pyrrolidine, piperidine and morpholine; l is a Linker selected: - ch = N -- (chu2082) - or - C (o) - NH -; ru1d43 is cu2081u208bu2086 linear or branched alkyl, cycloalkyl alquenilo cu2082u208bu2086 linear or branched alkyl or phenyl cu2083u208bu2086; ru1d47 is cu2081u208bu2086 linear or branched, alquenilo cu2082u208bu2086 linear or branched, cu2083u208bu2086 cycloalkyl alkyl or phenyl ru1d9c is cu2081u208bu2086 Lin; Alquenilo cu2082u208bu2086 EAL or branched, linear or branched,Cu2083u208bu2086 cycloalkyl alkyl or phenyl; ru00b9 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; Ru00b2 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b3 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru2074 is cu2081u208bu2086 linear or branched Cu2083u208bu2086 or cycloalkyl or ru00b3 and ru2074; taken together with the nitrogen Atom to which they are United to form a Ring of pyrrolidinePiperidine and morpholine; p is an integer number of 2, 3 and 4; s is an integer selected from 0 and 1; t is an integer of 0 and 1 is selected; with a compound of formula (5) in which: ru1d48 is a linear or branched alkyl cu2081u208bu2086; ru1d49, ru1da0 and ru1d4d are independently alkyl Cu2081u208bu2086 linear or branched, alquenilo cu2082u208bu2086 linear or branched.Cu2083u208bu2086 cycloalkyl or phenyl; and wu00b9 wu00b2 are independently 0 OR 1; in a mixture of water / alkanol.Claim 13: a Monomer, which is used as the precursor of the process according to claim 1, wherein it is formula (1) wherein R is selected from the group consisting of compounds of the formula (2), (3) and (4) in which: ru00b9, Ru00b2, ru00b3 and, ru2074 ru2075 Selection An independently of the group consisting of H, alkyl or cycloalkyl cu2083u208bu2086 cu2081u208bu2086 linear, branched, oru00b9u2070,Nhu2082, nhru00b9u00b9, nru00b9u00b2ru00b9u00b3, COOH, cooru00b9u2074, conhu2082, conhru00b9u2075, conru00b9u2076ru00b9u2077, sou2082nhu2082, sou2082nhru00b9u2078 sou2082nru00b9u2079ru00b2u2070, and under the condition that at least one of ru00b9, Ru00b2, ru00b3, ru2074 and ru2075 is not H provided that at least one ru00b9 and ru2075 h; ru2076, ru2077, ru2078 and ru2079 is selected inde Whether Hydrogen cu2081u208bu2086 linear or branched alkyl, cycloalkyl, cu2083u208bu2086, oru00b9, nhu2082,Nhru00b2 and nru00b3ru2074; ru00b9u2070 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; ru00b9u00b9 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u00b2 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u00b3 is linear or branched alkyl cu2081u208bu2086 or cycle Rent cu2083u208bu2086; or ru00b9u00b2 and ru00b9u00b3 taken together with the nitrogen Atom to which they are United to form a Ring of pyrrolidineRu00b9u2074 alkyl morpholine or piperidine; cu2081u208bu2086 is linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u2075 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u2076 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b9u2077 is linear or ramificad cu2081u208bu2086 Cu2083u208bu2086 or cycloalkyl or ru00b9u2076 and ru00b9u2077; taken together with the nitrogen Atom to which they are United to form a Ring of pyrrolidinePiperidine and morpholine; ru00b9u2078 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; ru00b9u2079 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; ru00b2u2070 is linear or branched alkyl or cycloalkyl cu2081u208bu2086 cu2083u208bu2086; or ru00b9u2079 and ru00b2u2070 taken together with the NITROGEN Atom that are United to form a Ring of pyrrolidine, piperidine and morpholine; l is a Linker selected: CH = N -- (chu2082) - or - C (o) - NH -; ru1d43 is cu2081u208bu2086 linear or branched alkyl, cycloalkyl alquenilo cu2082u208bu2086 linear or branched alkyl or phenyl cu2083u208bu2086; ru1d47 is cu2081u208bu2086 linear or branched, alquenilo cu2082u208bu2086 linear or branched, cu2083u208bu2086 cycloalkyl alkyl or phenyl ru1d9c is cu2081u208bu2086 Lin; Alquenilo cu2082u208bu2086 EAL or branched, linear or branched,Cu2083u208bu2086 cycloalkyl alkyl or phenyl; ru00b9 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; Ru00b2 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru00b3 is cu2081u208bu2086 linear or branched alkyl or cycloalkyl cu2083u208bu2086; ru2074 is cu2081u208bu2086 linear or branched Cu2082u208bu2086 or cycloalkyl or ru00b3 and ru2074; taken together with the nitrogen Atom to which they are United to form a Ring of pyrrolidineMORPHOLINE or piperidine, p is an integer selected 2, 3 and 4; s is an integer selected from 0 and 1; t is an integer of 0 OR 1 and selected; enantiu00f3meras forms, or Cosmetics or dermatologically acceptable salts thereof.
机译:本申请涉及颗粒形式的含有苯甲酸酯的有机硅聚合物,其制备方法,皮肤病学或化妆品组合物,以及其用于保护人或动物体内的紫外线辐射的用途。权利要求1 :一种制备逐步有机硅光刻胶聚合物的方法,其特征在于它包括式(1)的单体的反应:其中R选自式(2),(3)和(4),其中R 3选自直链或支链的烷基,环烷基,环烷基或环烷基,其中R 1和R 2分别独立地选自H,C 1,R 2和R 7。 u2083 u208b u2086或 u00b9 u2070,nh u2082,nhr u00b9 u00b9,nr u00b9 u00b2r u00b9 u00b3,COOH,coor u00b9 u2074,conh u2082,conhr u00b9 ,conr u00b9 u2076r u00b9 u2077,so u2082nh u2082,so u2082nhr u00b9 u2078 so u2082nr u00b9 u2079r u00b2 u2070,并且条件为tha t r u00b9,r u00b2,r u00b3,r u2074和r u2075中的至少一个不总是h h r u00b9和r u2075 h中的至少一个;无论氢如何选择r u2076,r u2077,r u2078和r u2079,直链或支链烷基,环烷基,c u2083 u208b u2086或 u00b9,nh u2082, Nhr u00b2和nr u00b3r u2074; r u00b9 u2070是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086; r u00b9 u00b9是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u00b2是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u00b3是直链或支链烷基c u2081 u208b u2086或循环租金c u2083 u208b u2086;或r u00b9 u00b2和r u00b9 u00b3与它们所结合的氮原子一起形成吡咯烷环R u00b9 u2074烷基吗啉或哌啶;或c u2081 u208b u2086是直链或支链的烷基或环烷基c u2083 u208b u2086; r u00b9 u2075是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u2076是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u2077是线性或支链的c u2081 u208b u2086 C u2083 u208b u2086或环烷基或r u00b9 u2076和r u00b9 u2077;与它们所结合的氮原子一起形成吡咯烷哌啶和吗啉环; r u00b9 u2078是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086; r u00b9 u2079是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086; r u00b2 u2070是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086;或r u00b9 u2079和r u00b2 u2070与NITROGEN Atom结合在一起,形成吡咯烷,哌啶和吗啉环; l是选择的链接器:-ch = N-(ch u2082)-或-C(o)-NH-; r u1d43为c u2081 u208b u2086直链或支链烷基,环烷基烷基n c20 u2082 u208b u2086直链或支链烷基或苯基c u2083 u208b u2086; r u1d47是c u2081 u208b u2086直链或支链,alquenilo c u2082 u208b u2086直链或支链,c u2083 u208b u2086环烷基或苯基r u1d9c是c u2081 u208b u2086 ; Alquenilo c u2082 u208b EAL或支链,直链或支链的,C u2083 u208b u20b环烷基烷基或苯基; r u00b9为c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; R c20是直链或支链的烷基或环烷基c 20 7208; r u00b3为c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u2074是c u2081 u208b u2086线性或支链C u2083 u208b u2086或环烷基或r u00b3和r u2074;与它们所结合的氮原子一起形成吡咯烷哌啶和吗啉环; p是2、3和4的整数; s是从0到1中选择的整数; t是0的整数,并且选择了1;具有式(5)的化合物,其中:r u1d48是直链或支链烷基c u2081 u208b u2086; r u1d49,r u1da0和r u1d4d独立为烷基C u2081 u208b u2086直链或支链的,alquenilo c u2082 u208b u20b直链或支链的。C u2083 u208b u20b u20b环烷基或苯基;和w u00b9 w u00b2独立为0或1;权利要求13:用作根据权利要求1的方法的前体的单体,其中它是式(1),其中R 2选自式(1)的化合物。 2),(3)和(4),其中:r u00b9,R u00b2,r u00b3和r u2074 r u2075选择一个独立于H,烷基或环烷基的c u2083 u208b u2086 c u2081 u208b u2086线性,分支或 u00b9 u2070,Nh u2082,nhr u00b9 u00b9,nr u00b9 u00b2r u00b9 u00b3,COOH,coor u00b9 u2072,conh ,conhr u00b9 u2075,conr u00b9 u2076r u00b9 u2077,so u2082nh u2082,so u2082nhr u00b9 u2078 so u2082nr u00b9 u2079r u00b2 u2070,并且在r u00b9,r u00b2,r u00b3,r u2074和r u2075中至少有一个不是H的条件下,前提是至少有一个r u00b9和r u2075 h;选择r u2076,r u2077,r u2078和r u2079,无论是氢c u2081 u208b u2086直链或支链烷基,环烷基,c u2083 u208b u2086或 u00b9,nh u2082, Nhr u00b2和nr u00b3r u2074; r u00b9 u2070是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086; r u00b9 u00b9是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u00b2是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u00b3是直链或支链烷基c u2081 u208b u2086或循环租金c u2083 u208b u2086;或r u00b9 u00b2和r u00b9 u00b3与它们所结合的氮原子一起形成吡咯烷环R u00b9 u2074烷基吗啉或哌啶;或c u2081 u208b u2086是直链或支链的烷基或环烷基c u2083 u208b u2086; r u00b9 u2075是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u2076是c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u00b9 u2077是线性或支链的c u2081 u208b u2086 C u2083 u208b u2086或环烷基或r u00b9 u2076和r u00b9 u2077;与它们所结合的氮原子一起形成吡咯烷哌啶和吗啉环; r u00b9 u2078是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086; r u00b9 u2079是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086; r u00b2 u2070是直链或支链烷基或环烷基c u2081 u208b u2086 c u2083 u208b u2086;或r u00b9 u2079和r u00b2 u2070与NITROGEN Atom结合在一起,形成吡咯烷,哌啶和吗啉环; l是选择的连接子:CH = N-(ch u2082)-或-C(o)-NH-; r u1d43为c u2081 u208b u2086直链或支链烷基,环烷基烷基n c20 u2082 u208b u2086直链或支链烷基或苯基c u2083 u208b u2086; r u1d47是c u2081 u208b u2086直链或支链,alquenilo c u2082 u208b u2086直链或支链,c u2083 u208b u2086环烷基或苯基r u1d9c是c u2081 u208b u2086 ; Alquenilo c u2082 u208b EAL或支链,直链或支链的,C u2083 u208b u20b环烷基烷基或苯基; r u00b9为c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; R c20是直链或支链的烷基或环烷基c 20 7208; r u00b3为c u2081 u208b u2086直链或支链烷基或环烷基c u2083 u208b u2086; r u2074是c u2081 u208b u2086直链或支链C u2082 u208b u2086或环烷基或r u00b3和r u2074; p是与它们相连的氮原子一起形成吡咯烷环或哌啶环,p是选自2、3和4的整数; s是从0到1中选择的整数; t是0或1的整数,并且已选择;对映体形式或其化妆品或皮肤病学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号